LONDON (Reuters) - GlaxoSmithKline is to acquire its long-time partner Human Genome Sciences for $3 billion, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer.
via Reuters: Health News Read More Here..
No comments:
Post a Comment